Home
/
Centessa Pharmaceuticals plc
/
Financials
/
Quarterly
Centessa Pharmaceuticals plc — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Centessa Pharmaceuticals plc filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$0
Nov 5, 2025
Q2
2025
Jun 30, 2025
$0
Aug 12, 2025
Q1
2025
Mar 31, 2025
$15.00M
May 14, 2025
Q3
2025
Sep 30, 2024
$0
Nov 5, 2025
Q2
2025
Jun 30, 2024
$0
Aug 12, 2025
Q1
2025
Mar 31, 2024
$0
May 14, 2025
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($54.89M)
Nov 5, 2025
Q2
2025
Jun 30, 2025
($50.34M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($26.14M)
May 14, 2025
Q3
2025
Sep 30, 2024
($42.57M)
Nov 5, 2025
Q2
2025
Jun 30, 2024
($43.82M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($38.05M)
May 14, 2025
Q3
2024
Sep 30, 2023
($38.65M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($24.89M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($50.71M)
May 13, 2024
Q3
2023
Sep 30, 2022
($53.88M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($64.66M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($54.50M)
May 12, 2023
Q3
2022
Sep 30, 2021
($40.16M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($41.45M)
Aug 10, 2022
Q3
2021
Jun 30, 2021
($41.45M)
Nov 15, 2021
Q1
2022
Mar 31, 2021
($238.69M)
May 16, 2022
Q2
2021
Mar 31, 2021
($238.69M)
Aug 16, 2021
Q3
2021
Mar 31, 2021
($238.69M)
Nov 15, 2021
Q2
2022
Jan 29, 2021
($829.0K)
Aug 10, 2022
Q3
2022
Jan 29, 2021
($829.0K)
Nov 10, 2022
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($53.79M)
Nov 5, 2025
Q2
2025
Jun 30, 2025
($54.65M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($30.78M)
May 14, 2025
Q3
2025
Sep 30, 2024
($46.41M)
Nov 5, 2025
Q2
2025
Jun 30, 2024
($43.98M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($36.09M)
May 14, 2025
Q3
2024
Sep 30, 2023
($40.21M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($47.02M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($48.88M)
May 13, 2024
Q3
2023
Sep 30, 2022
($49.03M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($68.41M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($53.22M)
May 12, 2023
Q3
2022
Sep 30, 2021
($38.31M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($41.29M)
Aug 10, 2022
Q1
2022
Mar 31, 2021
($236.19M)
May 16, 2022
Q1
2022
Jan 29, 2021
($783.0K)
May 16, 2022
Q2
2022
Jan 29, 2021
($783.0K)
Aug 10, 2022
Q3
2022
Jan 29, 2021
($783.0K)
Nov 10, 2022
Q3
2021
Sep 30, 2020
($2.12M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($2.13M)
Aug 16, 2021